Status:

RECRUITING

Efficacy of Early Inspiratory Muscle Training in Lung Transplanted Patients

Lead Sponsor:

Puerta de Hierro University Hospital

Collaborating Sponsors:

Universidad Complutense de Madrid

Conditions:

Lung Transplant Recipients

Muscle Weakness

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Lung transplantation is an effective therapeutic option in the end-stage of chronic respiratory diseases. Lung transplantation improves lung function in terms of capacity and volume. However, the tran...

Detailed Description

For many years, lung transplantation has become an effective therapeutic option for end-stage chronic lung diseases. With transplantation, an improvement in lung function is achieved, achieving volume...

Eligibility Criteria

Inclusion

  • Alert or able to cooperate with treatment.
  • Able to give Informed Consent and sign it.
  • Haemodynamically stable clinical situation or requiring minimal ventilatory support.

Exclusion

  • Detection of complete paralysis of the diaphragm.
  • Progressive neuromuscular diseases or with spinal cord injury.
  • Lack of collaboration or cooperation, or non-alertness (Glasgow ≤8).
  • Unstable clinical situation (patients requiring high levels of ventilatory support (e.g., Positive End Expiratory Pressure (PEEP)\> 10 cmH2O, Fraction Pressure of Inspired Oxygen (FiO2)\> 0.60, nitric oxide, nebulised prostacyclin, high frequency oscillation).
  • Clinical situation compromising the patient's recovery (cardiac arrhythmias, acute sepsis).
  • When the medical treatment team and/or physiotherapy consider that there may be risks.
  • Severe pain or dyspnoea that interferes with or impedes the ability to breathe (e.g. rib fracture).
  • Patients with lung retransplantation.
  • Heart and lung transplant patients.
  • When the patient is on palliative treatment

Key Trial Info

Start Date :

February 4 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 30 2025

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT05271019

Start Date

February 4 2022

End Date

April 30 2025

Last Update

April 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Laura Muelas Gómez

Majadahonda, Madrid, Spain, 28222